OTTAWA, Ontario — Health Canada records indicate that at least 23 deaths and 600 adverse reactions have been reported among women taking the birth-control pills (BCPs) Yaz and Yasmin (Bayer) in that country.
News of the reports was first reported by the Canadian Broadcasting Corporation (CBC) and has been widely picked up by Canadian media [1].
Adverse-reactions reports, reviewed by heartwire , show that a total of 333 distinct cases, including 15 deaths, were collected for Yasmin and 267 for Yaz, including eight deaths.
The Health Canada database includes adverse reports collected between 2007 and February 28, 2013.
The most common categories of adverse reports for both products are nervous system, vascular, and respiratory/thoracic/mediastinal disorders, but cardiac disorders were not infrequently listed. For Yasmin, cardiac disorders are listed as the primary system organ class in 4.1% of cases; for Yaz, that number was 6.6%.
No comments:
Post a Comment